Journal of Pharmacology and Pharmacotherapeutics · 2012 · 12 citations · 14 references
MedicinePediatricsPharmacologyEpilepsyPediatric Clinical PharmacologyPediatric PharmacotherapyAntiepileptic PharmacologyAntiepileptic PharmacotherapyDrug-induced Skin ReactionsPediatric Adverse Drug ReactionsAntiepileptic Drug ReactionsAntiepileptic Drug SafetyCutaneous Drug ReactionsEarly Case DetectionLamotrigine PharmacologyLamotrigine TreatmentPediatric Antiepileptic Therapy
A 12-year-male child developed toxic epidermal necrolysis (TEN) probably due to lamotrigine. The patient was on antiepileptic therapy (sodium valproate and clonazepam) since 6-7 months, and lamotrigine was added in the regimen 1-2 months back. A serious cutaneous reaction is more likely to occur during the first 2 months of starting lamotrigine. The use of lamotrigine as an add-on to valproate may have precipitated the reaction. Other drugs were ruled out based on the incubation period of TEN. Drug interactions should be kept in mind with multiple antiepileptic therapies. The patient died because of the severity of reactions and delay in starting the treatment with steroids. One must be vigilant in early detection of the reaction.
14
A method for estimating the probability of adverse drug reactions
C. A. Naranjo, U. Busto, Edward M. Sellers et al. · Clinical Pharmacology & Therapeutics · 1981 · 11.6K citations
Focusing on the preventability of adverse drug reactions.
Glen T. Schumock, John P. Thornton · PubMed · 1992 · 608 citations